Autor: |
Navratil JS; University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, PA, USA. joa8+@pitt.edu, Korb LC, Ahearn JM |
Jazyk: |
angličtina |
Zdroj: |
Immunopharmacology [Immunopharmacology] 1999 May; Vol. 42 (1-3), pp. 47-52. |
DOI: |
10.1016/s0162-3109(99)00018-1 |
Abstrakt: |
Complete deficiency of C1q, the first component of the classical pathway of complement activation, is almost invariably associated with the development of systemic lupus erythematosus. Understanding why complement deficiency results in the specific autoimmune phenotype of SLE may provide valuable clues to the role of complement in the maintenance of immune tolerance. The following review will focus on the characteristics of complement-deficient SLE and the experimental evidence in support of our hypothesis that C1q may critically influence the immune response to self-antigen contained within surface blebs generated by apoptotic cells. |
Databáze: |
MEDLINE |
Externí odkaz: |
|